The CFO's $245K purchase alongside the poison pill adoption signals strong insider conviction and a potential takeover scenario. Traders should watch for a Schedule 13D filing from an accumulating entity, which would confirm the defensive rationale. The stock may see upward pressure as the market digests the protective rights plan and insider alignment.
Price Chart
Executive Summary
Three insiders at Greenland Mines Ltd (GRML), including CFO Jeff LeBlanc, purchased $326K in open-market shares over a 7-day window ending July 22, 2026 — representing 1.09% of the company's $30M market cap. The buying cluster coincides with the board's adoption of a poison pill (Rights Agreement) on July 21, 2026, suggesting insiders were acting on knowledge of a potential takeover defense or undervaluation. The CFO's $245K purchase is the largest and carries strong conviction.
Key Financial Metrics
Key Facts
- CFO Jeff LeBlanc bought 1.4M shares at $0.18 for $245K on July 16, 2026
- Director Jon McGarity bought 140K shares at $0.1773 for $24.8K on July 20, 2026
- Director Jason David Sawyer bought 240K shares at $0.2331 for $55.9K on July 22, 2026
- Total insider purchases: $326K = 1.09% of $30M market cap
- Board adopted a poison pill (Rights Agreement) on July 21, 2026, triggering a shareholder rights plan
- All three insider trades occurred before or on the day of the poison pill adoption, before public disclosure on July 23
Financial Impact
Insider purchases of $326K represent 1.09% of market cap, a significant cluster
Risk Factors
- The poison pill may deter a premium takeover bid, capping upside
- The company is a micro-cap with limited liquidity, increasing volatility risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GRML-1784815315350 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-1 | $5.76 | awaiting T+1 | — | $5.79 (+0.51%) |
Oct 6, 2026 20d ago | Press Release | $6.38 $5.83 | ▼ −8.62% | ▼ −8.38% | $5.79 (−9.25%) |
Oct 5, 2026 21d ago | Press Release | $7.34 $6.38 | ▼ −13.08% | ▼ −13.63% | $5.79 (−21.12%) |
Sep 24, 2026 4w ago | Press Release | $14.89 $14.66 | ▲ +1.54% | ▲ +2.09% | $5.79 (+61.11%) |
Sep 23, 2026 4w ago | 424B5 | $14.89 $14.66 | ▲ +1.54% | ▲ +2.09% | $5.79 (+61.11%) |
Sep 23, 2026 4w ago | 8-K | $14.89 $14.66 | ▲ +1.54% | ▲ +2.09% | $5.79 (+61.11%) |
Sep 23, 2026 4w ago | 424B5 | $11.19 $14.89 | ▲ +33.07% | ▲ +33.15% | $5.79 (−48.26%) |
Sep 23, 2026 4w ago | Press Release | $11.19 $14.89 | ▲ +33.07% | ▲ +33.15% | $5.79 (−48.26%) |
Sep 22, 2026 4w ago | Institutional Cluster | $14.15 $11.19 | ▼ −20.92% | ▼ −20.20% | $5.79 (−59.08%) |
Sep 21, 2026 5w ago | Press Release | $9.42 $14.15 | ▲ +50.21% | ▲ +50.23% | $5.79 (−38.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers